About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 569831, 12 pages
http://dx.doi.org/10.1155/2013/569831
Review Article

Inflammatory Factors and Exercise in Chronic Kidney Disease

1School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire LE11 3TU, UK
2Leicester Kidney Exercise Team, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK
3Department of Infection, Immunity and Inflammation, Maurice Shock Medical Sciences Building, University Road, Leicester LE1 9HN, UK

Received 28 December 2012; Revised 19 April 2013; Accepted 19 April 2013

Academic Editor: Stephen L. Atkin

Copyright © 2013 Maurice Dungey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Longmore, I. B. Wilkinson, E. H. Davidson, A. Foulkes, and A. R. Mafi, Oxford Handbook of Clinical Medicine, Oxford University Press, Oxford, UK, 8th edition, 2010.
  2. National Collaborating Centre for Chronic Conditions, Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care, Royal College of Physicians, London, UK, 2008.
  3. R. Steenkamp, C. Castledine, T. Feest, and D. Fogarty, “UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses,” Nephron, vol. 119, no. 2, pp. 27–52, 2011.
  4. P. J. Kumar and M. L. Clark, Kumar and Clark's Clinical Medicine, Saunders Elsevier, Edinburgh, UK, 7th edition, 2009.
  5. Q. L. Zhang and D. Rothenbacher, “Prevalence of chronic kidney disease in population-based studies: systematic review,” BMC Public Health, vol. 8, no. 117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tonelli, N. Wiebe, B. Culleton et al., “Chronic kidney disease and mortality risk: a systematic review,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 2034–2047, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. S. Keith, G. A. Nichols, C. M. Gullion, J. B. Brown, and D. H. Smith, “Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization,” Archives of Internal Medicine, vol. 164, no. 6, pp. 659–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Drey, P. Roderick, M. Mullee, and M. Rogerson, “A population-based study of the incidence and outcomes of diagnosed chronic kidney disease,” American Journal of Kidney Diseases, vol. 42, no. 4, pp. 677–684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Sarnak, A. S. Levey, A. C. Schoolwerth et al., “Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention,” Circulation, vol. 108, no. 17, pp. 2154–2169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. L. Schiffrin, M. L. Lipman, and J. F. E. Mann, “Chronic kidney disease: effects on the cardiovascular system,” Circulation, vol. 116, no. 1, pp. 85–97, 2007. View at Publisher · View at Google Scholar
  11. P. Libby P, “Inflammation and cardiovascular disease mechanisms,” The American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 456–460, 2006.
  12. N. Khansari, Y. Shakiba, and M. Mahmoudi, “Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer,” Recent Patents on Inflammation and Allergy Drug Discovery, vol. 3, no. 1, pp. 73–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. X. Garg, P. G. Blake, W. F. Clark, C. M. Clase, R. B. Haynes, and L. M. Moist, “Association between renal insufficiency and malnutrition in older adults: results from the NHANES III,” Kidney International, vol. 60, no. 5, pp. 1867–1874, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Ortega, I. Rodriguez, P. Gallar et al., “Significance of high C-reactive protein levels in pre-dialysis patients,” Nephrology Dialysis Transplantation, vol. 17, no. 6, pp. 1105–1109, 2002. View at Scopus
  15. B. P. Oberg, E. McMenamin, F. L. Lucas et al., “Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease,” Kidney International, vol. 65, no. 3, pp. 1009–1016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Zaoui and R. M. Hakim, “The effects of the dialysis membrane on cytokine release,” Journal of the American Society of Nephrology, vol. 4, no. 9, pp. 1711–1718, 1994. View at Scopus
  17. W. E. M. Schouten, M. P. C. Grooteman, A. J. van Houte, M. Schoorl, J. van Limbeek, and M. J. Nubé, “Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis,” Nephrology Dialysis Transplantation, vol. 15, no. 3, pp. 379–384, 2000. View at Scopus
  18. G. A. Kaysen, “Inflammation nutritional state and outcome in end stage renal disease,” Mineral and Electrolyte Metabolism, vol. 25, no. 4–6, pp. 242–250, 1999. View at Scopus
  19. M. Arici and J. Walls, “End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?” Kidney International, vol. 59, no. 2, pp. 407–414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. C. L. Meuwese, S. Snaedal, N. Halbesma et al., “Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1313–1318, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Tripepi, F. Mallamaci, and C. Zoccali, “Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. S83–S88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. D. V. Barreto, F. C. Barreto, S. Liabeuf et al., “Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease,” Kidney International, vol. 77, no. 6, pp. 550–556, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Ouchi, J. L. Parker, J. J. Lugus, and K. Walsh, “Adipokines in inflammation and metabolic disease,” Nature Reviews Immunology, vol. 11, no. 2, pp. 85–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. N. D. Vaziri, M. V. Pahl, A. Crum, and K. Norris, “Effect of uremia on structure and function of immune system,” Journal of Renal Nutrition, vol. 22, no. 1, pp. 149–156, 2012. View at Publisher · View at Google Scholar
  25. A. Steensberg, C. P. Fischer, C. Keller, K. Møller, and B. K. Pedersen, “IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans,” American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 2, pp. E433–E437, 2003. View at Scopus
  26. W. W. Cheung, K. H. Paik, and R. H. Mak, “Inflammation and cachexia in chronic kidney disease,” Pediatric Nephrology, vol. 25, no. 4, pp. 711–724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. Carrero and P. Stenvinkel, “Inflammation in end-stage renal disease-what have we learned in 10 years?” Seminars in Dialysis, vol. 23, no. 5, pp. 498–509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Kalantar-Zadeh, “Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next?” Seminars in Dialysis, vol. 18, no. 5, pp. 365–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. W. F. Wilson, R. B. D’Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998.
  30. K. Kalantar-Zadeh, T. A. Ikizler, G. Block, M. M. Avram, and J. D. Kopple, “Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences,” American Journal of Kidney Diseases, vol. 42, no. 5, pp. 864–881, 2003. View at Scopus
  31. G. Strassmann, M. Fong, J. S. Kenney, and C. O. Jacob, “Evidence for the involvement of interleukin 6 in experimental cancer cachexia,” Journal of Clinical Investigation, vol. 89, no. 5, pp. 1681–1684, 1992. View at Scopus
  32. R. PecoitsFilho, P. Bárány, B. Lindholm, O. Heimbürger, and P. Stenvinkel, “Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment,” Nephrology Dialysis Transplantation, vol. 17, no. 9, pp. 1684–1688, 2002. View at Publisher · View at Google Scholar
  33. M. Barbieri, L. Ferrucci, E. Ragno et al., “Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons,” American Journal of Physiology—Endocrinology and Metabolism, vol. 284, no. 3, pp. E481–E487, 2003. View at Scopus
  34. D. Mafra, A. Jolivot, P. Chauveau et al., “Are ghrelin and leptin involved in food intake and body mass index in maintenance hemodialysis?” Journal of Renal Nutrition, vol. 20, no. 3, pp. 151–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Cheung, P. X. Yu, B. M. Little, R. D. Cone, D. L. Marks, and R. H. Mak, “Role of leptin and melanocortin signaling in uremia-associated cachexia,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1659–1665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Stenvinkel, M. Ketteler, R. J. Johnson et al., “IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly,” Kidney International, vol. 67, no. 4, pp. 1216–1233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Girndt, H. Kohler, E. Schiedhelm-Weick, J. F. Schlaak, K. H. Meyer Zum Buschenfelde, and B. Fleischer, “Production of interleukin-6, tumor necrosis factor α and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients,” Kidney International, vol. 47, no. 2, pp. 559–565, 1995. View at Scopus
  38. K. Kalantar-Zadeh, G. Block, C. J. McAllister, M. H. Humphreys, and J. D. Kopple, “Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients,” The American Journal of Clinical Nutrition, vol. 80, no. 2, pp. 299–307, 2004. View at Scopus
  39. American College of Sports Medicine, “Exercise is Medicine,” 2012, http://exerciseismedicine.org/physicians.htm.
  40. C. Kasapis and P. D. Thompson, “The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1563–1569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. E. A. Bermudez, N. Rifai, J. Buring, J. E. Manson, and P. M. Ridker, “Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1668–1673, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. T. S. Church, C. E. Barlow, C. P. Earnest, J. B. Kampert, E. L. Priest, and S. N. Blair, “Associations between cardiorespiratory fitness and C-reactive protein in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1869–1876, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. L. H. Colbert, M. Visser, E. M. Simonsick, et al., “Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study,” Journal of the American Geriatrics Society, vol. 52, no. 7, pp. 1098–1104, 2004. View at Publisher · View at Google Scholar
  44. R. Elosua, B. Bartali, J. M. Ordovas, A. M. Corsi, F. Lauretani, and L. Ferrucci, “Association between physical activity, physical performance, and inflammatory biomarkers in an elderly population: the InCHIANTI study,” Journals of Gerontology. A. Biological Sciences and Medical Sciences, vol. 60, no. 6, pp. 760–767, 2005. View at Scopus
  45. R. A. Shanely, D. C. Nieman, D. A. Henson, F. Jin, A. M. Knab, and W. Sha, “Inflammation and oxidative stress are lower in physically fit and active adults,” Scandinavian Journal of Medicine and Science in Sports, vol. 23, no. 2, pp. 215–223, 2011. View at Publisher · View at Google Scholar
  46. M. Hamer, S. Sabia, G. D. Batty et al., “Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study,” Circulation, vol. 126, no. 8, pp. 928–933, 2012. View at Publisher · View at Google Scholar
  47. T. Christiansen, S. K. Paulsen, J. M. Bruun, S. B. Pedersen, and B. Richelsen, “Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study,” American Journal of Physiology—Endocrinology and Metabolism, vol. 298, no. 4, pp. E824–E831, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. T. S. Church, C. P. Earnest, A. M. Thompson et al., “Exercise without weight loss does not reduce C-reactive protein: the INFLAME study,” Medicine and Science in Sports and Exercise, vol. 42, no. 4, pp. 708–716, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. L. K. Stewart, C. P. Earnest, S. N. Blair, and T. S. Church, “Effects of different doses of physical activity on C-reactive protein among women,” Medicine and Science in Sports and Exercise, vol. 42, no. 4, pp. 701–707, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Thompson, D. Markovitch, J. A. Betts, D. Mazzatti, J. Turner, and R. M. Tyrrell, “Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial,” Journal of Applied Physiology, vol. 108, no. 4, pp. 769–779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, “The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease,” Nature Reviews Immunology, vol. 11, no. 9, pp. 607–615, 2011. View at Publisher · View at Google Scholar
  52. M. Uguccioni, M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini, “Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes,” European Journal of Immunology, vol. 25, no. 1, pp. 64–68, 1995. View at Scopus
  53. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Keophiphath, C. Rouault, A. Divoux, K. Clément, and D. Lacasa, “CCL5 promotes macrophage recruitment and survival in human adipose tissue,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 1, pp. 39–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. L. Abramson and V. Vaccarino, “Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults,” Archives of Internal Medicine, vol. 162, no. 11, pp. 1286–1292, 2002. View at Scopus
  56. B. K. Pedersen and M. A. Febbraio, “Muscle as an endocrine organ: focus on muscle-derived interleukin-6,” Physiological Reviews, vol. 88, no. 4, pp. 1379–1406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Ostrowski, T. Rohde, S. Asp, P. Schjerling, and B. K. Pedersen, “Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans,” Journal of Physiology, vol. 515, part 1, pp. 287–291, 1999. View at Scopus
  58. C. P. Fischer, “Interleukin-6 in acute exercise and training: what is the biological relevance?” Exercise Immunology Review, vol. 12, pp. 6–33, 2006. View at Scopus
  59. J. M. Peake, K. Nosaka, M. Muthalib, and K. Suzuki, “Systemic inflammatory responses to maximal versus submaximal lengthening contractions of the elbow flexors,” Exercise Immunology Review, vol. 12, pp. 72–85, 2006. View at Scopus
  60. M. D. Phillips, J. B. Mitchell, L. M. Currie-Elolf, R. C. Yellott, and K. A. Hubing, “Influence of commonly employed resistance exercise protocols on circulating IL-6 and indices of insulin sensitivity,” Journal of Strength and Conditioning Research, vol. 24, no. 4, pp. 1091–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Keller, A. Steensberg, A. K. Hansen, C. P. Fischer, P. Plomgaard, and B. K. Pedersen, “Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle,” Journal of Applied Physiology, vol. 99, no. 6, pp. 2075–2079, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. B. K. Pedersen and C. P. Fischer, “Beneficial health effects of exercise–the role of IL-6 as a myokine,” Trends in Pharmacological Sciences, vol. 28, no. 4, pp. 152–156, 2007. View at Publisher · View at Google Scholar
  63. M. G. Flynn and B. K. McFarlin, “Toll-like receptor 4: link to the anti-inflammatory effects of exercise?” Exercise and Sport Sciences Reviews, vol. 34, no. 4, pp. 176–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Gleeson, B. McFarlin, and M. Flynn, “Exercise and Toll-like receptors,” Exercise Immunology Review, vol. 12, pp. 34–53, 2006. View at Scopus
  65. B. Stengel, M. E. Tarver-Carr, N. R. Powe, M. S. Eberhardt, and F. L. Brancati, “Lifestyle factors, obesity and the risk of chronic kidney disease,” Epidemiology, vol. 14, no. 4, pp. 479–487, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. N. Bharakhada, T. Yates, M. J. Davies, et al., “Association of sitting time and physical activity with CKD: a cross-sectional study in family practices,” American Journal of Kidney Diseases, vol. 60, no. 4, pp. 583–590, 2012. View at Publisher · View at Google Scholar
  67. A. M. O'Hare, K. Tawney, P. Bacchetti, and K. L. Johansen, “Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2,” American Journal of Kidney Diseases, vol. 41, no. 2, pp. 447–454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. A. G. Stack, D. A. Molony, T. Rives, J. Tyson, and B. V. R. Murthy, “Association of physical activity with mortality in the US dialysis population,” American Journal of Kidney Diseases, vol. 45, no. 4, pp. 690–701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Akber, A. A. Portale, and K. L. Johansen, “Pedometer-assessed physical activity in children and young adults with CKD,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 5, pp. 720–726, 2012. View at Publisher · View at Google Scholar
  70. K. L. Johansen and P. Painter, “Exercise in individuals with CKD,” American Journal of Kidney Diseases, vol. 59, no. 1, pp. 126–134, 2011.
  71. E. Brodin, S. Ljungman, and K. S. Sunnerhagen, “Rising from a chair: a simple screening test for physical function in predialysis patients,” Scandinavian Journal of Urology and Nephrology, vol. 42, no. 3, pp. 293–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Padilla, J. Krasnoff, M. Da Silva et al., “Physical functioning in patients with chronic kidney disease,” Journal of Nephrology, vol. 21, no. 4, pp. 550–559, 2008. View at Scopus
  73. R. G. Fassett, I. K. Robertson, D. P. Geraghty, M. J. Ball, N. W. Burton, and J. S. Coombes, “Physical activity levels in patients with chronic kidney disease entering the LORD trial,” Medicine and Science in Sports and Exercise, vol. 41, no. 5, pp. 985–991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Clyne, T. Jogestrand, L. E. Lins, and S. K. Pehrsson, “Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity,” Nephron, vol. 67, no. 3, pp. 322–326, 1994. View at Scopus
  75. E. Segura-Orti, P. L. Gordon, J. W. Doyle, et al., “Physical functioning in chronic kidney disease: contribution of uremia,” Journal of the American Society of Nephrology, vol. 21, pp. 669A–670A, 2010.
  76. F. Baria, M. A. Kamimura, C. M. Avesani et al., “Activity-related energy expenditure of patients undergoing hemodialysis,” Journal of Renal Nutrition, vol. 21, no. 3, pp. 226–234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. P. L. Gordon, J. W. Doyle, and K. L. Johansen, “Postdialysis fatigue is associated with sedentary behavior,” Clinical Nephrology, vol. 75, no. 5, pp. 426–433, 2011. View at Scopus
  78. S. Anand, G. M. Chertow, K. L. Johansen et al., “Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study,” Journal of Renal Nutrition, vol. 21, no. 6, pp. 429–437, 2011. View at Publisher · View at Google Scholar
  79. D. Mafra, P. Deleaval, D. Teta et al., “Influence of inflammation on total energy expenditure in hemodialysis patients,” Journal of Renal Nutrition, vol. 21, no. 5, pp. 387–393, 2011. View at Publisher · View at Google Scholar
  80. S. Zamojska, M. Szklarek, M. Niewodniczy, and M. Nowicki, “Correlates of habitual physical activity in chronic haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 21, no. 5, pp. 1323–1327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. F. G. Shiraishi, F. Stringuetta Belik, O. e Silva, et al., “Inflammation, diabetes, and chronic kidney disease: role of aerobic capacity,” Experimental Diabetes Research, vol. 2012, Article ID 750286, 6 pages, 2012. View at Publisher · View at Google Scholar
  82. G. C. Kosmadakis, A. Bevington, A. C. Smith et al., “Physical exercise in patients with severe kidney disease,” Nephron—Clinical Practice, vol. 115, no. 1, pp. c7–c15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Heiwe and S. H. Jacobson, “Exercise training for adults with chronic kidney disease,” Cochrane Database of Systematic Reviews, no. 10, Article ID CD003236, 2011. View at Publisher · View at Google Scholar
  84. M. Daniilidis, E. Kouidi, A. Fleva, et al., “The immune response in hemodialysis patients following physical training,” Journal of Sport Sciences for Health, vol. 1, no. 1, pp. 11–16, 2004. View at Publisher · View at Google Scholar
  85. B. S. B. Cheema, H. Abas, B. C. Smith, et al., “Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial,” European Journal of Applied Physiology, vol. 111, no. 7, pp. 1437–1445, 2011. View at Publisher · View at Google Scholar
  86. J. D. Kopple, H. Wang, R. Casaburi et al., “Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle,” Journal of the American Society of Nephrology, vol. 18, no. 11, pp. 2975–2986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. N. D. Toussaint, K. R. Polkinghorne, and P. G. Kerr, “Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients,” Hemodialysis International, vol. 12, no. 2, pp. 254–263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. K. R. Wilund, E. J. Tomayko, P. T. Wu et al., “Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study,” Nephrology Dialysis Transplantation, vol. 25, no. 8, pp. 2695–2701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Gołębiowski, M. Kusztal, W. Weyde, et al., “A program of physical rehabilitation during hemodialysis sessions improves the fitness of dialysis patients,” Kidney and Blood Pressure Research, vol. 35, no. 4, pp. 290–296, 2012. View at Publisher · View at Google Scholar
  90. A. Załuska, W. T. Załuska, A. Bednarek-Skublewska, and A. Ksiazek, “Nutrition and hydration status improve with exercise training using stationary cycling during hemodialysis (HD) in patients with end-stage renal disease (ESRD),” Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, vol. 57, no. 2, pp. 342–346, 2002. View at Scopus
  91. B. C. Nindl, S. A. Headley, A. P. Tuckow et al., “IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients,” Growth Hormone & IGF Research, vol. 14, no. 3, pp. 245–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Cheema, H. Abas, B. Smith et al., “Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis,” Journal of the American Society of Nephrology, vol. 18, no. 5, pp. 1594–1601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Afshar, L. Shegarfy, N. Shavandi, and S. Sanavi, “Effects of aerobic exercise and resistance training on lipid profiles and inflammation status in patients on maintenance hemodialysis,” Indian Journal of Nephrology, vol. 20, no. 4, pp. 185–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Afshar, A. Emany, A. Saremi, N. Shavandi, and S. Sanavi, “Effects of intradialytic aerobic training on sleep quality in hemodialysis patients,” Iranian Journal of Kidney Diseases, vol. 5, no. 2, pp. 119–123, 2011. View at Scopus
  95. S. Headley, M. Germain, P. Mailloux et al., “Resistance training improves strength and functional measures in patients with end-stage renal disease,” American Journal of Kidney Diseases, vol. 40, no. 2, pp. 355–364, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Castaneda, P. L. Gordon, R. C. Parker, K. L. Uhlin, R. Roubenoff, and A. S. Levey, “Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease,” American Journal of Kidney Diseases, vol. 43, no. 4, pp. 607–616, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. S. Headley, M. Germain, C. Milch, et al., “Exercise Training Improves HR responses and VO2peak in Predialysis Kidney Patients,” Medicine and Science in Sports and Exercise, vol. 44, no. 12, pp. 2392–2399, 2012. View at Publisher · View at Google Scholar
  98. D. J. Leehey, I. Moinuddin, J. P. Bast et al., “Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study,” Cardiovascular Diabetology, vol. 8, article 62, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Haddad, F. Zaldivar, D. M. Cooper, and G. R. Adams, “IL-6-induced skeletal muscle atrophy,” Journal of Applied Physiology, vol. 98, no. 3, pp. 911–917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. E. M. Macy, T. E. Hayes, and R. P. Tracy, “Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications,” Clinical Chemistry, vol. 43, no. 1, pp. 52–58, 1997. View at Scopus
  101. J. A. Eustace, B. Astor, P. M. Muntner, T. A. Ikizler, and J. Coresh, “Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease,” Kidney International, vol. 65, no. 3, pp. 1031–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. G. A. V. Borg, “Perceived exertion: a note on “ history” and methods,” Medicine and Science in Sports and Exercise, vol. 5, no. 2, pp. 90–93, 1973.
  103. N. P. E. Kadoglou, F. Iliadis, N. Angelopoulou et al., “The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus,” European Journal of Cardiovascular Prevention and Rehabilitation, vol. 14, no. 6, pp. 837–843, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Trøseid, K. T. Lappegrd, T. E. Mollnes, H. Arnesen, and I. Seljeflot, “The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome,” Metabolic Syndrome and Related Disorders, vol. 7, no. 6, pp. 579–583, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. E. Goldhammer, A. Tanchilevitch, I. Maor, Y. Beniamini, U. Rosenschein, and M. Sagiv, “Exercise training modulates cytokines activity in coronary heart disease patients,” International Journal of Cardiology, vol. 100, no. 1, pp. 93–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. A. I. Larsen, P. Aukrust, T. Aarsland, and K. Dickstein, “Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure,” American Journal of Cardiology, vol. 88, no. 7, pp. 805–808, 2001. View at Scopus
  107. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. G. Garibotto, A. Sofia, V. Procopio et al., “Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and microinflammatory state,” Kidney International, vol. 70, no. 2, pp. 384–390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. G. Romano, R. Simonella, E. Falleti et al., “Physical training effects in renal transplant recipients,” Clinical Transplantation, vol. 24, no. 4, pp. 510–514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. H. L. MacLaughlin, P. A. Sarafidis, S. A. Greenwood, K. L. Campbell, W. L. Hall, and I. C. Macdougall, “Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease,” American Journal of Hypertension, vol. 25, no. 9, pp. 1024–1029, 2012. View at Publisher · View at Google Scholar
  111. J. Axelsson, A. R. Qureshi, M. E. Suliman et al., “Truncal fat mass as a contributor to inflammation in end-stage renal disease,” The American Journal of Clinical Nutrition, vol. 80, no. 5, pp. 1222–1229, 2004. View at Scopus
  112. A. Merino, P. Buendia, A. Martin-Malo, P. Aljama, R. Ramirez, and J. Carracedo, “Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity,” Journal of Immunology, vol. 186, no. 3, pp. 1809–1815, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. K. U. Belge, F. Dayyani, A. Horelt et al., “The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF,” Journal of Immunology, vol. 168, no. 7, pp. 3536–3542, 2002. View at Scopus
  114. P. Gollapudi, J. W. Yoon, S. Gollapudi, M. V. Pahl, and N. D. Vaziri, “Leukocyte toll-like receptor expression in end-stage kidney disease,” American Journal of Nephrology, vol. 31, no. 3, pp. 247–254, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. T. K. Hendrikx, E. A. F. J. van Gurp, W. M. Mol et al., “End-stage renal failure and regulatory activities of CD4 +CD25bright+FoxP3+ T-cells,” Nephrology Dialysis Transplantation, vol. 24, no. 6, pp. 1969–1978, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. P. Meier, D. Golshayan, E. Blanc, M. Pascual, and M. Burnier, “Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD,” Journal of the American Society of Nephrology, vol. 20, no. 6, pp. 1368–1384, 2009. View at Publisher · View at Google Scholar